Section 6 presents an emergency boost for the immune system at the beginning of a respiratory infection.
Learn some protective measures to consider in order to reduce your risk of contracting Coronavirus (COVID-19) and other viral illnesses.
Category: biotech/medical – Page 1841
3 minutes for glaucoma eye surgery.
Cataract and glaucoma are eye diseases that progress by aging. Both are severe diseases that can cause blindness, but in Japan, unique treatment methods and causes are being investigated. For cataracts, the world is paying attention to a Japanese doctor who has devised an innovative surgical method which is in just over 3 minutes. And distinctive research is progressing at Japanese universities as to what kind of ingredients can delay the progression of glaucoma. How can we save people from blindness? Explore with us the forefront of Japanese ophthalmic medical care.
Gene Therapy for Glaucoma
Posted in biotech/medical
:oooo.
A novel approach to treat glaucoma is reported that achieves reduced intraocular pressure by combining intravitreal adeno-associated virus (AAV) gene delivery to the ciliary body with selective CRISPR-Cas9-mediated disruption of Aquaporin 1. Translational viability is assessed using both human ex vivo ciliary body cultures and two experimental mouse models.
Even since Alexander Fleming stumbled across penicillin—the first antibiotic drug—scientists knew our fight with evolution was on.
Most antibiotics work by blocking biological processes that allow bacteria to thrive and multiply. With prolonged, low-dosage use, however, antibiotics become a source of pressure that forces bacteria to evolve—and because these microorganisms are extremely adept at swapping and sharing bits of their DNA, when one member becomes resistant, so does most of its population.
Even more terrifying is this: because the same family of antibiotics generally act on the same biological pathways, when bacteria generate a mutation that resists one type of drug, it often renders that entire family of drugs useless.
The National Institutes of Health is testing the antiviral drug remdesivir, which is also being studied in patients in China. Running trials during epidemics is tricky, but scientists learned a lot about how to conduct them during recent Ebola outbreaks.
Feline coronaviruses (FCoVs) are the causative agents of severe systemic disease (feline infectious peritonitis: FIP) in domestic and wild cats. FCoVs have been classified into serotypes I and II. Type I FCoV is the dominant serotype (approximately 70–90%) worldwide. Therefore, it is necessary to provide antiviral agents for type I FCoV infection. In this study, we demonstrated that itraconazole (ICZ), practically used for fungal infections in cats, inhibits the type I FCoV infection. ICZ also exhibited antiviral effect in cells after viral infection, suggesting that ICZ could potentially be used as a therapeutic.
But using porous TCP to print bones does have some drawbacks. Its compressive strength is much lower than that of some human load-bearing bones, such as our thighbones. Compressive strength would rise over time, but it could be years before it would match pre-operation strength levels.
3D Printing Bones for Mars?
Several other groups are working on similar approaches. At NYU School of Medicine and NYU Langone Health, scientists have been developing 3D printed scaffold implants that could help patient groups such as children with skull deform ities. Early research results show that up to 77 percent of the bone scaffolding had been absorbed and replaced by natural bone 6 months after surgery, and that the newly-grown bone was just as strong as the original.
BEIJING (Reuters) — A Chinese company says it has developed the country’s first facial recognition technology that can identify people when they are wearing a mask, as most are these days because of the coronavirus, and help in the fight against the disease.